Transaction in Own Shares
9 August 2018 - Experian plc, the global information services company (the "Company"), hereby notifies the market, in conformity with Listing Rule 12.4.6R, of the following: -
Further to the announcement by the Company on 17 May 2018 of a share repurchase programme, the Company announces that it has purchased its ordinary shares of 10 US cents each ("Shares") on the London Stock Exchange through Merrill Lynch International as follows:
Date and time of purchase: 9 August 2018 - 16:29
Number of Shares purchased (aggregate volume): 120,031
Lowest price per share: 1891.0000 pence
Highest price per share: 1900.0000 pence
Weighted average price: 1897.7927 pence
The Shares purchased will be cancelled.
All transactions under this programme will be published on the Company's website (www.experianplc.com) on a weekly basis.
Ronan Hanna Deputy Company Secretary +353 (0) 1 846 9128
Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.
We have 16,500 people operating across 39 countries and every day we're investing in new technologies, talented people and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.
Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.